| Financial Year |
March 31 2023 |
| Monetary Funds |
2,356,094,911.98 |
| Held-for-trading Financial Assets |
96,860,844.23 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,845,819,425.66 |
| Advances to Suppliers |
47,756,040.99 |
| Other Receivables |
30,482,953.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
990,803,471.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,666,858.08 |
| Total Current Assets |
6,520,009,880.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,149,665.88 |
| Fixed Assetes |
1,432,918,441.27 |
| Under-construction Projects |
355,187,645.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,732,745.89 |
| R&D expenses |
-- |
| Goodwill |
1,821,386.63 |
| Long-Term Deferred and Prepaid Expenses |
416,488.80 |
| Deferred Income Tax Assets |
43,769,173.08 |
| Other Non-Current Assets |
275,297,843.05 |
| Sub-Total of Non-Current Assets |
2,318,978,054.91 |
| Total Assets |
8,838,987,935.34 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,453,608,033.37 |
| Accounts Payable |
1,367,660,550.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
100,026,593.70 |
| Taxes Payable |
38,835,401.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
123,865,540.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,399,717.57 |
| Other Current Liabilities |
2,461,116.17 |
| Sub-Total of Current Liabilities |
3,107,788,616.18 |
| Long-term Loans |
-- |
| Bonds Payable |
674,680,325.35 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
84,678,860.07 |
| Deferred Income Tax Liabilities |
25,101,019.95 |
| Other Non-Current Liabilities |
63,830,000.00 |
| Sub-Total of Non-Current Liabilities |
986,295,074.19 |
| Total Liabilities |
4,094,083,690.37 |
| Paid-In Capital(Or Share Stock) |
411,784,084.00 |
| Capital Surplus |
944,512,427.00 |
| Surplus Reserve |
205,913,487.50 |
| LESS:Treasury Stock |
81,995,098.25 |
| Undistributed Profits |
2,692,411,013.41 |
| Minority Stockholder's Interest |
358,789,703.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,386,114,541.29 |
| Owner's Equity（Stockholder's Equity） |
4,744,904,244.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,838,987,935.34 |
